BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 9099911)

  • 1. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
    Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
    Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
    Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND
    Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription.
    Han Y; Watling D; Rogers NC; Stark GR
    Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro expression of long and short ovine prolactin receptors: activation of Jak2/STAT5 pathway is not sufficient to account for prolactin signal transduction to the ovine beta-lactoglobulin gene promoter.
    Bignon C; Daniel N; Belair L; Djiane J
    J Mol Endocrinol; 1999 Oct; 23(2):125-36. PubMed ID: 10514551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F; Chiarenza A; Goffin V; Kelly PA
    Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.
    Pezet A; Ferrag F; Kelly PA; Edery M
    J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
    Ali S; Ali S
    J Biol Chem; 1998 Mar; 273(13):7709-16. PubMed ID: 9516478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
    Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
    Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
    J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor.
    Pezet A; Buteau H; Kelly PA; Edery M
    Mol Cell Endocrinol; 1997 May; 129(2):199-208. PubMed ID: 9202403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
    Jabbour HN; Critchley HO; Boddy SC
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription.
    Gouilleux F; Wakao H; Mundt M; Groner B
    EMBO J; 1994 Sep; 13(18):4361-9. PubMed ID: 7925280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin-independent modulation of the beta-casein response element by Erk2 MAP kinase.
    Gao J; Horseman ND
    Cell Signal; 1999 Mar; 11(3):205-10. PubMed ID: 10353695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580.
    DaSilva L; Rui H; Erwin RA; Howard OM; Kirken RA; Malabarba MG; Hackett RH; Larner AC; Farrar WL
    Mol Cell Endocrinol; 1996 Mar; 117(2):131-40. PubMed ID: 8737372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway.
    Prigent-Tessier A; Barkai U; Tessier C; Cohen H; Gibori G
    Endocrinology; 2001 Mar; 142(3):1242-50. PubMed ID: 11181541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin receptor and signal transduction to milk protein genes.
    Djiane J; Daniel N; Bignon C; Paly J; Waters M; Vacher P; Dufy B
    Proc Soc Exp Biol Med; 1994 Jul; 206(3):299-303. PubMed ID: 8016168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant negative and cooperative effects of mutant forms of prolactin receptor.
    Perrot-Applanat M; Gualillo O; Pezet A; Vincent V; Edery M; Kelly PA
    Mol Endocrinol; 1997 Jul; 11(8):1020-32. PubMed ID: 9212050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.